Boswellia 400 mg

A 500 mg branded Boswellin extract plus 200 mg of turmeric extract broadens joint-focused ingredient coverage beyond the original plain 400 mg Boswellia extract. Boswellic-acid and curcuminoid percentages remain partly unclear.

Glucosamine sulfate, 100 mg of ApresFlex Boswellia, 40 mg of standardized cartilage, and boron create a more complete joint formula beyond the original plain 400 mg Boswellia extract. The recurring cost is higher, and the boron amount is modest.

A 100 mg 5-Loxin extract, 40 mg of UC-II, turmeric, and ginger provide several complementary joint-support ingredients beyond the original plain 400 mg Boswellia extract. Willow bark may be unsuitable for aspirin-sensitive people or those using anticoagulant or antiplatelet medicines.

A focused 600 mg Boswellia gum-resin extract supplies a substantial single-ingredient amount at a lower serving cost than the original plain 400 mg Boswellia extract. The boswellic-acid percentage and an enhanced delivery method are not supplied.

A 500 mg Boswellia extract in a lipid-containing softgel provides a substantial, focused amount at a lower serving cost than the original plain 400 mg Boswellia extract. The active-acid percentages are unclear despite the useful amount and softgel format.

Whole Boswellia plus a named 200 mg Boswellin extract provides broader plant material at a lower serving cost than the original plain 400 mg Boswellia extract. The supplied facts do not state the active-acid percentages.

Glucosamine, 100 mg of 5-Loxin, and a chondroitin/MSM complex provide broader joint coverage while lowering the serving cost relative to the original plain 400 mg Boswellia extract. The combined chondroitin/MSM amount does not disclose how much of each ingredient is present.

A 500 mg frankincense extract with 7.5 mg of black pepper provides a focused formula with an absorption-oriented addition while lowering the serving cost relative to the original plain 400 mg Boswellia extract. The boswellic-acid and AKBA percentages are not supplied, and the leucine adds little independent value.

A 350 mg standardized Boswellia extract plus 70 mg of powder provides a substantial focused serving while lowering the serving cost relative to the original plain 400 mg Boswellia extract. The active-acid percentages and a separate absorption aid are not supplied.